Bio-Techne (NASDAQ:TECH) just reported results for the fourth quarter of 2024.
- Bio-Techne reported earnings per share of 49 cents. This met the analyst estimate for EPS of 49 cents.
- The company reported revenue of $306.10 million.
- This was 0.13% worse than the analyst estimate for revenue of $306.49 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/08/tech-stock-earnings-bio-techne-for-q4-of-2024/.
©2024 InvestorPlace Media, LLC